Legal issues have forced the stock well down. Not the kind of issues that most retail investors should get involved in. Prefers Health Management Associates (HMA-N) and HCA.
THC focuses on hospital operation and increasingly on ambulatory services across the US. It has been able to increase cash reserves, while aggressively retiring debt and buying back shares. It trades at 11x earnings, 3.1x book and supports a robust 110% ROE. We recommend setting a stop-loss at $120, looking to achieve $173 -- upside potential of 25%. Yield 0%
(Analysts’ price target is $173.53)
Your Watchlist
Add stocks to watchlist to monitor them daily and get important alerts.